drugset / Trial / NCT07675590
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
RandomizedSequentialQuadruple-blindTreatment
Summary
Randomized, Placebo-controlled Study to determine the safety and tolerability of multiple oral doses of TIX100 administered daily for 28 days to otherwise healthy overweight/obese subjects.
Timeline
- Start
- 2026-06-22
- Primary completion
- 2026-10
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TIX100 | Unknown | 40 mg | Oral |
| Comparator | TIX100 | Unknown | 80 mg | Oral |
| Comparator | TIX100 | Unknown | 120 mg | Oral |